Viewing Study NCT04550650



Ignite Creation Date: 2024-05-06 @ 3:12 PM
Last Modification Date: 2024-10-26 @ 1:44 PM
Study NCT ID: NCT04550650
Status: COMPLETED
Last Update Posted: 2022-04-05
First Post: 2020-09-10

Brief Title: Follow-up Study of the Effectiveness of Virtual Reality Therapy in MS Patients
Sponsor: Somogy Megyei Kaposi Mór Teaching Hospital
Organization: Somogy Megyei Kaposi Mór Teaching Hospital

Study Overview

Official Title: Follow-up Study of the Effectiveness of Virtual Reality Therapy in MS Patients
Status: COMPLETED
Status Verified Date: 2022-03
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Different therapies can improve clinical and motor symptoms of multiple sclerosis MS similarly but studies comparing the effects of different exercise therapies on clinical and motor outcomes are scant We compared the effects of exergaming EXE balance BAL cycling CYC proprioceptive neuromuscular facilitation PNF and a standard care wait-listed control group CON on clinical and motor symptoms and quality of life QoL in people with MS PwMS

Methods PwMS n 68 90 female age 470 yr Expanded Disability Status Scale score 5-6 were randomized into five groups Before and after the interventions five times a week for 5 wk PwMS were tested for MS-related clinical and motor symptoms Multiple Sclerosis Impact Scale-29 MSIS-29 primary outcome QoL EuroQol Five Dimensions Questionnaire symptoms of depression gait and balance ability Tinetti Assessment Tool static and dynamic balance and fall risk Berg Balance Scale walking capacity 6-min walk test and standing posturography on a force platform

Patients were followed up for 2 years after 5 weeks of intensive care Tests are performed every six months
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None